Altimmune, inc. (ALT)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Research grants and contracts

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

License revenue

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total revenue

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Revenue

5,058

5,801

7,814

9,804

10,595

10,331

0

0

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Contract revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,577

10,640

11,200

11,007

13,516

10,190

12,017

14,543

15,179

17,912

20,272

23,480

25,501

25,175

25,401

23,965

24,077

24,266

24,270

23,789

0

0

0

Operating expenses:
Research and development

21,735

17,765

17,957

13,956

15,930

18,459

19,854

21,031

21,367

18,406

16,356

12,851

8,978

7,221

5,983

4,708

4,549

5,133

5,753

6,356

7,506

9,319

11,626

12,453

13,483

15,290

15,939

18,521

20,037

19,509

19,293

19,039

20,104

21,219

22,860

23,916

0

0

0

General and administrative

8,766

8,500

8,905

8,682

9,384

9,765

8,939

10,014

8,874

8,457

8,520

8,771

7,943

7,106

6,425

4,366

5,219

6,222

7,868

9,829

10,430

10,911

12,870

13,764

13,676

13,279

11,323

10,512

10,960

11,628

11,682

11,690

12,319

14,311

14,810

15,648

0

0

0

Impairment charges

-

-

0

-

-

24,940

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Goodwill impairment charges

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restructuring expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,546

2,519

2,096

2,060

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

142

141

145

147

147

149

156

164

169

182

211

0

0

-

0

-

-

-

-

-

-

-

-

Depreciation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

0

0

0

0

0

Total operating expenses

31,501

27,266

52,313

47,088

49,764

53,165

38,604

67,456

66,652

62,783

51,439

21,585

16,884

14,327

12,505

9,629

10,395

14,043

16,286

18,430

20,144

20,381

24,653

26,382

27,330

28,751

27,471

29,270

31,268

31,442

31,323

31,119

32,854

35,992

38,278

40,312

0

0

0

Loss from operations

-26,443

-21,464

-44,498

-37,283

-39,168

-42,834

-28,052

-54,947

-53,522

-52,045

-42,926

-16,763

-14,354

-11,091

-8,586

-5,455

-5,818

-3,402

-5,085

-7,423

-6,628

-10,191

-12,635

-11,838

-12,150

-10,839

-7,198

-5,789

-5,766

-6,266

-5,921

-7,153

-8,776

-11,725

-14,007

-16,522

0

0

0

Other income (expense):
Changes in fair value of warrant liability

-

-

0

0

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Changes in fair value of warrant liability, including gain (loss) on exchange

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Realization of cumulative translation adjustment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

Changes in fair value of embedded derivative

-

-

-

-

-

184

0

0

0

-

0

-

-

-

-

-

1

299

621

-298

604

508

1,201

1,133

703

-444

-931

205

676

591

3,239

0

0

-

0

-

-

-

-

Interest expense

3

2

129

295

296

297

171

7

102

162

0

0

0

-

0

0

-

-

-

-

0

-

263

316

0

-

0

0

-

324

240

138

42

54

986

1,898

0

0

0

Interest income (expense), net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

0

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

Realization of cumulative translation adjustment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

0

0

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

Interest income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

Interest income

809

843

797

594

380

226

0

0

0

-

0

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

19

17

16

16

10

9

0

0

0

Other income - litigation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other income, net

-6

15

-17

37

66

277

284

264

264

5

50

43

37

42

3

-1

3

8

7

8

8

-0

-4

-3

0

-6

22

-9

-11

47

10

137

104

39

-42

-108

0

0

0

Change in fair value of derivative instruments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

Total other income, net

830

886

677

1,279

-4,084

-2,486

-1,871

-3,234

1,872

-18

-657

-177

-99

4

-259

94

-255

23

314

-642

446

297

944

834

366

-817

-1,307

1,008

1,469

1,541

3,209

4,599

4,525

7,928

5,132

1,288

0

0

0

Net loss before income tax benefit

-25,612

-20,578

-43,821

-36,004

-43,253

-45,320

-29,924

-58,182

-51,650

-52,063

0

0

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss before income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-6,073

-3,378

-4,771

-8,065

-6,181

-9,893

-11,690

-11,004

-11,783

-11,656

-8,506

-4,781

-4,296

-4,724

-2,712

-2,554

-4,251

-3,797

0

0

0

-

-

Income tax benefit

0

-

0

-

-

-6,149

0

0

0

-

0

0

-

-

-

-

57

61

71

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Income tax (provision) benefit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

0

0

0

-

0

0

0

-

-

-

-

-

-

Net loss

-22,308

-20,520

-40,931

-32,342

-38,094

-39,171

-23,494

-51,048

-45,020

-46,425

-41,042

-15,931

-14,438

-11,086

-8,877

-5,407

-6,131

-3,440

-4,831

-8,135

-6,233

-9,955

-11,750

-11,068

-11,865

-11,718

-8,563

-4,831

-4,351

-4,920

-2,901

-2,720

-4,401

-3,797

-8,874

-15,234

0

0

0

Other comprehensive loss — foreign currency translation adjustment

-

-

-

-

-

-463

0

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other comprehensive loss – unrealized loss on investments

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comprehensive loss

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other comprehensive income (loss) - foreign currency translation adjustments

-

-

-

-

-

-

-

-

-

-

-

0

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comprehensive loss

-

-

-40,912

-32,342

-

-

-21,768

-50,350

-41,986

-43,427

0

0

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss

-22,308

-20,520

-40,931

-32,342

-38,094

-39,171

-23,494

-51,048

-45,020

-46,425

0

0

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deemed dividends

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Preferred stock accretion and other deemed dividends

-

-

-

-

-

3,307

5,332

7,358

6,702

4,930

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Preferred stock accretion and dividends

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss attributed to common stockholders

-22,308

-20,973

-42,164

-33,512

-39,964

-42,478

-28,826

-58,406

-51,723

-51,355

0

0

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Weighted-average common shares outstanding, basic and diluted

15,110

15,113

14,768

13,127

9,489

8,255

1,321

956

676

-17,953

517

12,245

6,917

-50,581

6,911

6,911

64,404

-

-

-

-

-

58,952

54,670

-

52,361

52,166

49,749

48,359

48,350

48,345

48,325

48,269

48,224

48,194

46,631

46,276

-

-

Net loss per share attributed to common stockholders, basic and diluted

-0.26

-0.33

-0.74

-0.26

-0.27

4.35

-1.73

-10.29

-7.49

-56.40

-61.57

-0.26

-0.68

-0.68

-0.71

-0.25

-0.02

-

-

-

-

-

-0.08

-0.01

-

-0.09

-0.08

-0.02

-0.04

-0.02

0.00

-0.02

-0.06

0.01

0.00

-0.05

-0.04

-0.14

-0.22

Net income (loss) attributable to common stockholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Basic net income (loss) per share

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.01

-0.02

-0.04

0.02

-

-

-

-0.04

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Diluted net income (loss) per share

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.01

-0.02

-0.04

0.02

-

-

-

-0.04

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Weighted-average shares used in calculation of basic net income (loss) per share

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

64,377

64,187

63,745

63,633

-

-

-

53,044

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Weighted-average shares used in calculation of diluted net income (loss) per share

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

64,030

64,187

63,745

63,979

-

-

-

53,044

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Weighted average shares used in calculation of basic and diluted net loss per share

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

31,946

29,619